Febrile neutropenia: Antifungal prophylaxis

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 127-130

  Donnelly, J P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cochrane collaboration; Febrile neutropenia; Pre emptive therapy; Prophylaxis

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

COMPUTER ASSISTED TOMOGRAPHY; FEBRILE NEUTROPENIA; HUMAN; IMMUNE DEFICIENCY; INFECTION; MORTALITY; MYCOSIS; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; VIRUS INFECTION;

EID: 0033781959     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00217-X     Document Type: Article

References (20)

1. Meta analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia
2. The prophylaxis of bacterial infections in neutropenic patients
3. Current concepts: fever in immunocompromised patients
4. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation (see comments)
5. Fungal infections in cancer patients - an international autopsy survey
6. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group
7. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
8. Prospects for the early diagnosis of invasive aspergillois in the immunocompromised host
9. PCR-ELISA for the early diagnosis of invasive pulmonary Aspergillus infection in neutropenic patients
10. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
11. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia
12. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto
13. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. UK Multicentre Antifungal Prophylaxis Study Group
14. Pharmacokinetic optimisation of oral antifungal therapy
15. Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons
16. Parameters for the successful management of cytomegalovirus
17. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples
18. Two strategies for managing invasive aspergillosis: a decision analysis
19. Candida colonization and systemic infection in neutropenic patients
20. The value of fungal surveillance cultures as predictors of systemic fungal infections